Department of Clinical Neurosciences
Rockyview General Hospital - HCACC
7007 14 Street SW
Calgary, AB T2V 1P9
Another area of interest is working towards a standardized and validated definition of treatment failure and the risks and benefits of the various management options for those with aggressive and rapidly disabling MS including conventional chemotherapeutic agents and novel immunomodulators. I am also interested in the impact of pregnancy and reproductive hormones on MS activity.
Finally, I have an overall interest in clinical epidemiology and the design, methodology, and analysis of observational and clinical trials in MS and neurology in general.